Olympus sells scientific instruments business to Bain Capital

Olympus Corporation (“Olympus”) and EVIDENT Corporation ("EVIDENT"), a wholly-owned subsidiary of Olympus, closed a previous agreement with Bain Capital Private Equity, LP (“Bain Capital”) under which Olympus will transfer all shares of EVIDENT to Bain Capital for ¥427.6 billion (US$3.1 billion).

Evident is a world-leading manufacturer of microscopes for life science and industrial applications, videoscopes for remote visual inspection and non-destructive test equipment.

Torys acted as Canadian counsel to Olympus with a team that included Don Bell, Guillaume Lavoie and Ana Ioanas (corporate/M&A), Courtney Barbour, Nicole Baker and Nathan Little (due diligence), Ed Fan, Sue Fei and Michele Clarizio (IP), Cristelle Sary and Christophe Cinqmars-Viau (employment), Michael Fortier (environmental), Molly Reynolds (privacy) and Omar Wakil (competition).

Khaitan & Co assisted Olympus Corporation with a team led by Zakir Merchant.

Japanese law firm Nishimura & Asahi advised Bain Capital Private Equity, LP on its acquisition of all shares in Evident Corporation, with a team led by  partners Yuki Oi, Kohei Ishida, Takeshi Nemoto and Junko Wakabayashi.

UBS Capital Markets L.P acted as financial advisor to Bain Capital Private Equity, LP.

Merger & Acquisition
Tech/Computer/IT
$ 3,742,782,800
Closed
03 April 2023